Literature DB >> 28306504

Targeting of Polycomb Repressive Complex 2 to RNA by Short Repeats of Consecutive Guanines.

Xueyin Wang1, Karen J Goodrich1, Anne R Gooding1, Haroon Naeem2, Stuart Archer2, Richard D Paucek1, Daniel T Youmans3, Thomas R Cech4, Chen Davidovich5.   

Abstract

Polycomb repressive complex 2 (PRC2) is a histone methyltransferase that trimethylates H3K27, a mark of repressed chromatin. Mammalian PRC2 binds RNA promiscuously, with thousands of target transcripts in vivo. But what does PRC2 recognize in these RNAs? Here we show that purified human PRC2 recognizes G > C,U ≫ A in single-stranded RNA and has a high affinity for folded guanine quadruplex (G4) structures but little binding to duplex RNAs. Importantly, G-tract motifs are significantly enriched among PRC2-binding transcripts in vivo. DNA sequences coding for PRC2-binding RNA motifs are enriched at PRC2-binding sites on chromatin and H3K27me3-modified nucleosomes. Collectively, the abundance of PRC2-binding RNA motifs rationalizes the promiscuous RNA binding of PRC2, and their enrichment at Polycomb target genes provides a means for RNA-mediated regulation.
Copyright © 2017 Elsevier Inc. All rights reserved.

Entities:  

Keywords:  G-quadruplex; PRC2; Polycomb repressive complex 2; RNA binding specificity; motif; promiscuous RNA binding

Mesh:

Substances:

Year:  2017        PMID: 28306504     DOI: 10.1016/j.molcel.2017.02.003

Source DB:  PubMed          Journal:  Mol Cell        ISSN: 1097-2765            Impact factor:   17.970


  79 in total

Review 1.  RNA-mediated regulation of heterochromatin.

Authors:  Whitney L Johnson; Aaron F Straight
Journal:  Curr Opin Cell Biol       Date:  2017-06-11       Impact factor: 8.382

2.  TERRA regulate the transcriptional landscape of pluripotent cells through TRF1-dependent recruitment of PRC2.

Authors:  Rosa María Marión; Juan J Montero; Isabel López de Silanes; Osvaldo Graña-Castro; Paula Martínez; Stefan Schoeftner; José Alejandro Palacios-Fábrega; Maria A Blasco
Journal:  Elife       Date:  2019-08-20       Impact factor: 8.140

3.  RNA is essential for PRC2 chromatin occupancy and function in human pluripotent stem cells.

Authors:  Yicheng Long; Taeyoung Hwang; Anne R Gooding; Karen J Goodrich; John L Rinn; Thomas R Cech
Journal:  Nat Genet       Date:  2020-07-06       Impact factor: 38.330

Review 4.  Detecting RNA G-Quadruplexes (rG4s) in the Transcriptome.

Authors:  Chun Kit Kwok; Giovanni Marsico; Shankar Balasubramanian
Journal:  Cold Spring Harb Perspect Biol       Date:  2018-07-02       Impact factor: 10.005

Review 5.  Towards understanding of PRC2 binding to RNA.

Authors:  Junli Yan; Bibek Dutta; Yan Ting Hee; Wee-Joo Chng
Journal:  RNA Biol       Date:  2019-01-08       Impact factor: 4.652

6.  RNA exploits an exposed regulatory site to inhibit the enzymatic activity of PRC2.

Authors:  Qi Zhang; Nicholas J McKenzie; Robert Warneford-Thomson; Emma H Gail; Sarena F Flanigan; Brady M Owen; Richard Lauman; Vitalina Levina; Benjamin A Garcia; Ralf B Schittenhelm; Roberto Bonasio; Chen Davidovich
Journal:  Nat Struct Mol Biol       Date:  2019-03-04       Impact factor: 15.369

Review 7.  Noncoding RNAs Controlling Telomere Homeostasis in Senescence and Aging.

Authors:  Martina Rossi; Myriam Gorospe
Journal:  Trends Mol Med       Date:  2020-02-28       Impact factor: 11.951

8.  RNA-Binding Specificity of the Human Fragile X Mental Retardation Protein.

Authors:  Youssi M Athar; Simpson Joseph
Journal:  J Mol Biol       Date:  2020-04-25       Impact factor: 5.469

Review 9.  Targeting RNA in mammalian systems with small molecules.

Authors:  Anita Donlic; Amanda E Hargrove
Journal:  Wiley Interdiscip Rev RNA       Date:  2018-05-03       Impact factor: 9.957

10.  RNA-DNA strand exchange by the Drosophila Polycomb complex PRC2.

Authors:  Célia Alecki; Victoria Chiwara; Lionel A Sanz; Daniel Grau; Osvaldo Arias Pérez; Elodie L Boulier; Karim-Jean Armache; Frédéric Chédin; Nicole J Francis
Journal:  Nat Commun       Date:  2020-04-14       Impact factor: 14.919

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.